FindTrial
Sign In

Randomized controlled trial for vitamin D supplementation to improve metabolic syndrome in patients with depression

Randomized controlled trial for vitamin D supplementation to improve metabolic syndrome in patients with depression

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030130
Enrollment
Unknown
Registered
2020-02-24
Start date
2015-10-01
Completion date
Unknown
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Experimental group:Vitamin D Supplementation
Control group:No Vitamin D supplementation

Sponsors

Hefei Fourth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with depression who were hospitalized at the Fourth People's Hospital of Hefei from February 2018 to February 2019 were included as follows: (1) aged 18 to 60 years old; (2) no immediate family members with schizophrenia.

Exclusion criteria

Exclusion criteria: (1) Urethral calculi; (2) Vitamin D has been taken six months before; (3) Osteoporosis or fracture; (4) Dementia.

Design outcomes

Primary

MeasureTime frame
Serum 25(OH) D3 levels <=75nmol/L;—

Countries

China

Contacts

Public ContactDaoMin Zhu

Hefei Fourth People's Hospital

hfsyzdm7778@163.com+86 18655141567

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 17, 2026